Psoriasis breakthrough? single shot may keep skin clear for over a year

NCT ID NCT04630652

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looked at 24 adults with moderate-to-severe plaque psoriasis to understand how a single injection of risankizumab (Skyrizi) changes immune cells in the skin. The goal was to learn why some patients stay clear of psoriasis for up to 66 weeks without further treatment. Researchers took skin biopsies before and after the drug to track immune cell changes and build models that might predict who can achieve long-term remission.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Rockefeller Univesity

    New York, New York, 10065, United States

  • University of California Davis Medical Center

    Sacramento, California, 95817, United States

  • VA Northern California Health Care System

    Sacramento, California, 95655, United States